Wearable device data could predict New York Heart Association functional class similarly to clinical measures and six-minute walk test. HealthDay News — For patients with atrial fibrillation, digoxin ...

ORLANDO, Fla. (Ivanhoe Newswire) -Atrial fibrillation, called AFib, is the most common type of heart arrhythmia and experts say 12.1 million people in the U.S. will have AFib in 2030. While treatments ...

Our findings in a large, population-based registry of over 20 000 patients with a recent hospitalization for documented HF suggest that prescription of a non-selective beta-blocker is associated with ...

For over four decades, many heart attack survivors have been sent home with a prescription for beta-blockers, which are drugs that impact the effects of hormones and adrenaline on the heart and blood ...

ATLANTA — Beta blockers are a mainstay in cardiovascular treatment, frequently given to patients after heart attacks. But a new large trial turns that convention on its head, suggesting that the drugs ...

For 40 years, it has been the standard in post-heart attack health care, but a new study from the European Society of Cardiology is putting the usage of beta blockers in limbo. While the new study may ...

Propranolol and metoprolol are both beta-blockers, which are a class of drugs taken for heart conditions, including angina (chest pain), arrhythmias (heart rhythm disorders), and high blood pressure.